Phase III Study of Minocycline in Acute Spinal Cord Injury
Spinal Cord Injuries
Enrolment: 248 · Results not recorded
Drug · Bacterial 70S ribosome inhibitor (INHIBITOR; binding site 16S rRNA)
5 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Spinal Cord Injuries
Enrolment: 248 · Results not recorded
Spinal Tumours, Trauma Patients
Enrolment: 444 · Results not recorded
Traumatic Brain Injury
Enrolment: 672 · Results not recorded
Spinal Cord Injuries
Enrolment: 52 · Results not recorded
Traumatic Brain Injury
Enrolment: 15 · Results not recorded
Periodontitis
Enrolment: 51 · Results not recorded
Non-surgical Periodontal Therapy
Enrolment: 15 · Results not recorded
Neuropathic Pain Caused by Lumbar Radicular Pain
Enrolment: 60 · Results not recorded
Human Volunteer
Enrolment: 180 · Results not recorded
Infection Prevention
Enrolment: 326 · Results not recorded
Acinetobacter Infections
Enrolment: 94 · Results not recorded
Papulopustular Rosacea
Enrolment: 504 · Results not recorded
Oral Lichen Planus
Enrolment: 30 · Results not recorded
Retinitis Pigmentosa · Inherited Retinal Dystrophy
Enrolment: 126 · Results not recorded
Acute Stroke · Ischemic Stroke
Enrolment: 2 · Results not recorded
Colorectal Cancer
Enrolment: 122 · Results not recorded
Myeloma
Enrolment: 79 · Results not recorded
Post-operative Intercostal Neuralgia
Enrolment: 116 · Results not recorded
Depressive Disorder
Enrolment: 29 · Results not recorded
Oropharynx Cancer
Enrolment: 47 · Results not recorded
15 studies reported at therapy level; 21 evidence entries itemised.
Model: Contusive spinal cord injury
Acute treatment with minocycline loaded nanoparticles modulated resident microglia, reduced the pro-inflammatory response and maintained a pro-regenerative environment, improving behavioural outcome up to 63 days post injury. The approach also demonstrated a mechanistic link between early microglia…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.
Model: T9 contusion spinal cord injury
Minocycline or anti-CD25 antibody given during the chronic phase improved hindlimb locomotor function after spinal cord injury in mice.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Experimental spinal cord injury in a mouse model, with in vitro and in vivo assessment of the subacute phase of secondary injury
Minocycline loaded nanoparticles reduced activation and proliferation of microglia and macrophages around the lesion site, shifted cells from a round phagocytic-like phenotype towards an arborised resting-like phenotype with low CD68 staining, and reduced proinflammatory IL-6 expression with persis…
Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.
Model: Acute spinal cord contusion
Minocycline reduced plasma pNF-H levels, which correlated with better hind limb motor recovery after SCI.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Model: Closed-head injury by mechanical percussion
Minocycline attenuated olfactory behavioural deficit and olfactory bulb atrophy up to 12 weeks after traumatic brain injury.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.
Model: Weight-drop traumatic brain injury
Minocycline attenuated the post-TBI decrease in sAPPalpha and reduced long-term brain atrophy and gliosis.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Asphyxial cardiac arrest (5 min) followed by resuscitation
Minocycline transiently reduced neuronal degeneration and microglial response at 7 days (most effective given post-arrest) but the neuroprotection was lost by 21 days.
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Spinal cord hemisection
Dual-drug treatment reduced inflammation at 7 days, decreased scar tissue and increased neuronal regeneration at 28 days, and produced faster and sustained functional improvement compared with the other experimental groups.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
Model: Experimental spinal cord injury by weight compression method
Both drugs produced significant behavioural recovery, supported by histopathological, monoamine and oxidative stress findings, with the ranking FK506 plus minocycline greater than minocycline greater than FK506 across all parameters.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Repetitive impact traumatic brain injury modelling abusive head trauma, three impacts delivered 24 h apart in 11-day-old rats
Minocycline reduced microglial and macrophage reactivity in the corpus callosum at 3 days but not 7 days post-injury, had no effect on axonal injury, neurodegeneration or tissue atrophy, and exacerbated injury-induced spatial memory deficits.
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
Model: Insulin-induced severe acute hypoglycaemia under isoflurane anaesthesia and controlled ventilation: 10 U/kg regular insulin intraperitoneally, hypoglycaemia terminated after 30 min of isoelectric EEG by 0.2 mL of 50% glucose intravenously followed by continuous 1:1 50% glucose and Krebs-Henseleit infusion at 1.5 mL/h for 3 h; achieved blood glucose 0.40 plus or minus 0.03 mM (vehicle) and 0.38 plus or minus 0.01 mM (minocycline); mean arterial pressure maintained 120 to 180 mmHg; sham animals received the same insulin dose but were kept normoglycaemic with 25% glucose
Minocycline started 6 h after glucose reperfusion reduced hippocampal and cortical microglial activation and myeloperoxidase immunoreactivity, significantly increased surviving CA1 NeuN-positive neurons at 7 days and 8 weeks with fewer Fluoro-Jade B positive cells, and prevented hypoglycaemia-induc…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.
Model: Whole-body irradiation with 1-3 Gy cobalt-60 gamma rays
Minocycline increased splenic macrophages, granulocytes, natural killer, T and CD8+ T cells, raised IL-1alpha, IL-1beta, GM-CSF and G-CSF, and suppressed MIP-1alpha, TNF-alpha and interferon-gamma compared with radiation alone.
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
Model: Closed-head traumatic brain injury by mechanical percussion under anaesthesia
Closed-head injury produced a recognition memory deficit persisting to at least 13 weeks with no clear change in anxiety; minocycline attenuated the memory impairment in an effective and lasting manner.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Model: Endovascular perforation-induced subarachnoid haemorrhage
High-dose minocycline reduced brain water content and MMP-9 activity at 24 h, improved spatial memory and attenuated hippocampal and cortical neuronal loss; low-dose minocycline did not reduce brain oedema.
Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Unilateral entorhinal cortex lesion producing hippocampal deafferentation and reactive synaptogenesis
Osteopontin protein and transcript rose more than 50-fold in activated glia at 1 to 2 days after lesion. Minocycline attenuated MMP-9 activity, reduced LCN2 expression and osteopontin fragment generation, and attenuated removal of synapsin-1 positive axons from the deafferented zone. Osteopontin kn…
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
Model: Controlled cortical impact (1.5 mm) traumatic brain injury
Neither melatonin, minocycline nor their combination significantly improved cognitive or histological outcomes after TBI.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Extraction: mesh. Machine-extracted fields require source verification.
Extraction: mesh. Machine-extracted fields require source verification.
Extraction: mesh. Machine-extracted fields require source verification.
Extraction: mesh. Machine-extracted fields require source verification.
Extraction: mesh. Machine-extracted fields require source verification.